ArticleMolecular pharmaceutics2017

Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy.

Zilan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.